Enlil, Inc., a Shifamed Portfolio Company and leader in enabling MedTech product innovation, today announced new integrations ...
AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback